| Fibroblast growth factors, their receptors and signaling. CJ Powers, SW McLeskey, A Wellstein Endocrine-related cancer 7 (3), 165-197, 2000 | 1825 | 2000 |
| Immunolocalization of an FGF-binding protein reveals a widespread expression pattern during different stages of mouse embryo development A Aigner, PE Ray, F Czubayko, A Wellstein Histochemistry and cell biology 117, 1-11, 2002 | 628 | 2002 |
| Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin GE Stoica, A Kuo, A Aigner, I Sunitha, B Souttou, C Malerczyk, ... Journal of Biological Chemistry 276 (20), 16772-16779, 2001 | 510 | 2001 |
| Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types GE Stoica, A Kuo, C Powers, ET Bowden, EB Sale, AT Riegel, A Wellstein Journal of Biological Chemistry 277 (39), 35990-35998, 2002 | 467 | 2002 |
| Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma W Zhang, N Nandakumar, Y Shi, M Manzano, A Smith, G Graham, ... Science signaling 7 (324), ra42-ra42, 2014 | 385 | 2014 |
| Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer. W Fang, N Hartmann, DT Chow, AT Riegel, A Wellstein Journal of Biological Chemistry 267 (36), 25889-25897, 1992 | 321 | 1992 |
| A secreted FGF-binding protein can serve as the angiogenic switch in human cancer F Czubayko, EDE Liaudet-Coopman, A Aigner, AT Tuveson, GJ Berchem, ... Nature medicine 3 (10), 1137-1140, 1997 | 310 | 1997 |
| Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth C Powers, A Aigner, GE Stoica, K McDonnell, A Wellstein Journal of Biological Chemistry 277 (16), 14153-14158, 2002 | 252 | 2002 |
| Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus AM Schulte, S Lai, A Kurtz, F Czubayko, AT Riegel, A Wellstein Proceedings of the National Academy of Sciences 93 (25), 14759-14764, 1996 | 251 | 1996 |
| Effect of estradiol on estrogen receptor-α gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway GE Stoica, TF Franke, M Moroni, S Mueller, E Morgan, MC Iann, ... Oncogene 22 (39), 7998-8011, 2003 | 220 | 2003 |
| Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin F Czubayko, AM Schulte, GJ Berchem, A Wellstein Proceedings of the National Academy of Sciences 93 (25), 14753-14758, 1996 | 219 | 1996 |
| Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. F Czubayko, RV Smith, HC Chung, A Wellstein Journal of Biological Chemistry 269 (45), 28243-28248, 1994 | 191 | 1994 |
| The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis O Catalina-Rodriguez, VK Kolukula, Y Tomita, A Preet, F Palmieri, ... Oncotarget 3 (10), 1220, 2012 | 185 | 2012 |
| Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue HJ List, R Reiter, B Singh, A Wellstein, AT Riegel Breast cancer research and treatment 68, 21-28, 2001 | 184 | 2001 |
| Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells HJ List, KJ Lauritsen, R Reiter, C Powers, A Wellstein, AT Riegel Journal of Biological Chemistry 276 (26), 23763-23768, 2001 | 184 | 2001 |
| Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein E Tassi, A Al-Attar, A Aigner, MR Swift, K McDonnell, A Karavanov, ... Journal of Biological Chemistry 276 (43), 40247-40253, 2001 | 181 | 2001 |
| Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells YE Shi, J Torri, L Yieh, A Wellstein, ME Lippman, RB Dickson Cancer research 53 (6), 1409-1415, 1993 | 181 | 1993 |
| A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine. A Wellstein, WJ Fang, A Khatri, Y Lu, SS Swain, RB Dickson, J Sasse, ... Journal of Biological Chemistry 267 (4), 2582-2587, 1992 | 177 | 1992 |
| RNA Silencing In Vivo Reveals Role of p22phox in Rat Angiotensin Slow Pressor Response P Modlinger, T Chabrashvili, PS Gill, M Mendonca, DG Harrison, ... Hypertension 47 (2), 238-244, 2006 | 166 | 2006 |
| Estradiol rapidly activates Akt via the ErbB2 signaling pathway GE Stoica, TF Franke, A Wellstein, F Czubayko, HJ List, R Reiter, ... Molecular Endocrinology 17 (5), 818-830, 2003 | 164 | 2003 |
Achim AignerProfessor of Clinical Pharmacology, Leipzig University, Faculty of Medicine在 medizin.uni-leipzig.de 的电子邮件经过验证
